Inventor · disambiguated record
Katherine J. Kayser-Bricker
Also filed as: KAYSER-BRICKER KATHERINE · KAYSER-BRICKER KATHERINE J
11 granted patents·17 pending applications·106 citations·filing 2009–2024
90Inventor score
Files withFORMA THERAPEUTICS INC16HALDA THERAPEUTICS OPCO INC6SEBTI SAID M2VALO HEALTH INC2UNIV SOUTH FLORIDA1
Top patents by PatentIndex Score
28 records- 0197US10336722B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2019·22 cites·47 claims
- 0297US9422281B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Aug 23, 2016·25 cites·35 claims
- 0396US11111229B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·4 cites·22 claims
- 0496US10377769B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·10 cites·28 claims
- 0596US9388161B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Jul 12, 2016·34 cites·44 claims
- 0694US10611750B2Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 7, 2020·7 cites·38 claims
- 0787US10703764B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·2 cites·19 claims
- 0876US9453049B2Substrate-mimetic Akt inhibitorSEBTI SAID M·Filed 2014·Granted Sep 27, 2016·1 cites·13 claims
- 0976US8822524B2Substrate-mimetic Akt inhibitorSEBTI SAID M·Filed 2009·Granted Sep 2, 2014·1 cites·5 claims
- 1076US2023061891A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1174US11084831B1Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·0 cites·14 claims
- 1265US2016257699A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1360US9896668B2Substrate-mimetic AKT inhibitorUNIV SOUTH FLORIDA·Filed 2016·Granted Feb 20, 2018·0 cites·17 claims
- 1459US2016257692A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1556US2025136611A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2024·Application pending·0 cites
- 1654US2021346356A1Inhibiting ubiquitin specific peptidase 9xFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1752US2025388575A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 1852US2025388605A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 1951US2022213059A1Inhibiting usp19VALO HEALTH INC·Filed 2020·Application pending·0 cites
- 2050US2025032623A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2150US2025136619A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2249US2022204495A1Inhibiting trabidVALO HEALTH INC·Filed 2020·Application pending·0 cites
- 2349US2020268897A1Phosphatase Binding Compounds and Methods of Using SameUNIV YALE·Filed 2020·Application pending·0 cites
- 2448US2022041597A1Inhibiting ubiquitin specific peptidase 9xFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2547US2024408093A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2646US2023065368A1Inhibiting ubiquitin specific peptidase 9xFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2743US2016256458A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2843US2016256448A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katherine J. Kayser-Bricker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →